FTC sues major pharmacy benefit administrators about insulin selling prices The agency brought action against Caremark, Categorical Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating procedures “artificially inflated” the checklist price of everyday living-conserving insulin medicines. Since some electronic health and fitness startups funded for the duration of https://kethek.com/